• UCLA Health
  • myUCLAhealth
  • School of Medicine
U Magazine

U Magazine

U Magazine
  • Home
  • Current Issue
  • Centennial Campaign for UCLA Issue
  • Browse U Magazine
  • Letters to the Editor
  • Subscribe
  • Contact
  • UCLA Health
  • myUCLAhealth
  • School of Medicine

U Magazine

Browse U Magazine

  1. Home
  2. Browse U Magazine
Share this
The Cutting Edge

Stem-Cell Gene Therapy for Sickle Cell Advances Toward Clinical Trials

Human red blood cells made from bone-marrow stem cells of a patient with sickle-cell disease.Human red blood cells made from bone-marrow stem cells of a patient with sickle-cell disease. The red blood cells with BetaAS3 anti-sickling vector show the normal round shape, while those that were not corrected are sickle shaped. Photo: Courtesy of Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research

Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have successfully established the foundation for using hematopoietic (blood-producing) stem cells from the bone marrow of patients with sickle-cell disease to treat the illness. The study was led by Donald Kohn, MD, professor of pediatrics and of microbiology, immunology and molecular genetics.

Sickle-cell disease causes the body to produce misshapen red blood cells that form like the crescent-shaped blade of a sickle, which hinders blood flow and deprives the body’s organs of oxygen. Dr. Kohn introduced an anti-sickling gene into the hematopoietic stem cells to capitalize on the self-renewing potential of stem cells and create a continual source of healthy red blood cells that do not sickle. The breakthrough gene-therapy technique for sickle-cell disease is scheduled to begin clinical trials early next year.

Dr. Kohn’s autologous gene-therapy approach is a revolutionary alternative to current sickle-cell disease treatments, which include transplanting patients with donor hematopoietic stem cells. Such transplants offer a potential cure for sickle-cell disease, but due to the serious risks of rejection, only a small number of patients have undergone this procedure, and it is usually restricted to children with severe symptoms.

Dr. Kohn and colleagues found that in the laboratory, the hematopoietic stem cells produced new non-sickled blood cells at a rate sufficient for significant clinical improvement for patients. The new blood cells survive longer than sickled cells, which also could improve treatment outcomes.

More than 90,000 patients in the U.S. have been diagnosed with sickle-cell disease. It is caused by an inherited mutation in the beta-globin gene that makes red blood cells change from their normal shape, which is round and pliable, into a rigid, sickle-shaped cell. Normal red blood cells are able to pass easily through the tiniest blood vessels, carrying oxygen to organs throughout the body. But due to their rigid structure, sickled blood cells get stuck in the small capillaries.

“ß-globin Gene Transfer to Human Bone Marrow for Sickle Cell Disease,” Journal of Clinical Investigation, July 1, 2013


Previous
Exercise after School to Stay Fit
Next
WALL-E, Meet EVA: Robo-doc Navigates on Its Own


YOU ARE VIEWING

Fall 2013

Fall 2013
Printable PDF
IN THIS ISSUE
  • Too Small to Fail
  • Simple Screening Catches Newborn’s Hidden Heart Condition
  • Antihistamines May Pose Risk to Women with Severe Morning Sickness
  • Why Alzheimer’s Meds Rarely Help
  • New Clues to Cause of Human Narcolepsy
  • Exercise after School to Stay Fit
  • Stem-Cell Gene Therapy for Sickle Cell Advances Toward Clinical Trials
  • WALL-E, Meet EVA: Robo-doc Navigates on Its Own
  • Fat Chance: Scientists Accidently Discover Stress-Resistant Stem Cells in Adipose Tissue
  • Doctor-Patient Communication about Dietary Supplements Could Use a Vitamin Boost
  • New Learning Center Will Expand School's Capabilities
  • Nadereh Pourat, PhD
  • Faith & Healing
  • Live from L.A.
  • Joint Liability
  • Mulitasker
  • Awards/Honors
  • In Memoriam
  • In Her Own Words: Laura Pacha, MD ’98
  • Postcard from Tijuana, Mexico
  • In His Own Words: A Kidney for Francie
  • From Officer to Civilian
  • Golden Portal Awards
  • Awards/Honors
  • Events
  • Chairs of Distinction
  • Gifts
  • In Memoriam
  • Patient, Advocate for Thyself
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest
UCLA Health hospitals ranked best hospitals by U.S. News & World Report
  • UCLA Health
  • Find a Doctor
  • School of Medicine
  • School of Nursing
  • UCLA Campus
  • Directory
  • Newsroom
  • Subscribe
  • Patient Stories
  • Giving
  • Careers
  • Volunteer
  • International Services
  • Privacy Practices
  • Nondiscrimination
  • Billing
  • Health Plans
  • Emergency
  • Report Broken Links
  • Terms of Use
  • 1-310-825-2631
  • Maps & Directions
  • Contact Us
  • Your Feedback
  • Report Misconduct
  • Get Social
  • Sitemap
Like Us on Facebook Follow Us on Twitter Subscribe to Our Videos on YouTube Follow us on Instagram Connect with Us on LinkedIn Follow us on Pinterest

Sign in to myUCLAhealth